Nutralogix and Palm Beach Rejuvenation Center Form Major Alliance with $2 Million Revenue Potential for near Future from Resulting Sales

Business Wire, July 25, 2006

WESTON, Fla. -- Nutralogix Laboratories, Inc. (PINK SHEETS: NGXL) (http://www.nutralogixlabs.com), and the renowned Palm Beach Rejuvenation Center (PBR) (http://www.HghTest.com) reached an agreement for Palm Beach to use and market Nutralogix products, along with joint marketing, which could result in additional revenues for the Company that could reach or even surpass the $2 million level. Palm Beach Rejuvenation center is nationally and internationally known as one of the largest and finest Hormone Replacement and Age Management Clinics in the United States.

Palm Beach maintains a state-of-the-art clinic, along with a large active client base, sales over $11,000,000 yearly and growing, and an advertising budget for the internet alone, which exceeds $600,000 per year. The licensed clinic also maintains a major compounding pharmacy. The alliance speaks highly for the quality of product produced by Nutralogix, far beyond the normal standards of the supplement world.

"We welcome our new partners and believe that we can supply them with the finest of organic health, fitness, and anti-aging supplements, which will work hand-in-hand with Palm Beach Rejuvenation Center's advanced protocols. We consider this is be an enormous marketing breakthrough and believe that this alliance will greatly enhance the awareness, both nationally and worldwide of the quality of the Company's products," stated Troy Johnson, Nutralogix CEO.

"Palm Beach Rejuvenation Center customers will have access to our unique product line and we will have the good fortune to have PBR presenting our highest quality organic supplements to their highly sophisticated clientele. We believe that this is an extraordinary marketing partnership and look forward to a highly successful future with our allies at PBR," continued Johnson.

Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements are presented based on current information available to management and in consideration of assumptions concerning information available to management regarding future events. Forward-looking statements are subject to risks and uncertainties that could cause future events or results to differ materially from such statements. Nutralogix Laboratories, Inc. disclaims any intent or obligation to update or revise any forward-looking statements and presents information herein solely for the intent of delivering general information regarding the company.